Your browser doesn't support javascript.
loading
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
Räber, Lorenz; Ueki, Yasushi; Otsuka, Tatsuhiko; Losdat, Sylvain; Häner, Jonas D; Lonborg, Jacob; Fahrni, Gregor; Iglesias, Juan F; van Geuns, Robert-Jan; Ondracek, Anna S; Radu Juul Jensen, Maria D; Zanchin, Christian; Stortecky, Stefan; Spirk, David; Siontis, George C M; Saleh, Lanja; Matter, Christian M; Daemen, Joost; Mach, François; Heg, Dik; Windecker, Stephan; Engstrøm, Thomas; Lang, Irene M; Koskinas, Konstantinos C.
Afiliación
  • Räber L; Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Ueki Y; Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Otsuka T; Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Losdat S; CTU Bern, University of Bern, Bern, Switzerland.
  • Häner JD; Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Lonborg J; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Fahrni G; Department of Cardiology, University Hospital Basel, Basel, Switzerland.
  • Iglesias JF; Division of Cardiology, University Hospital Geneva, Geneva, Switzerland.
  • van Geuns RJ; Department of Cardiology, Radboud UMC, Nijmegen, the Netherlands.
  • Ondracek AS; Department of Cardiology, Medical University of Vienna, Vienna, Austria.
  • Radu Juul Jensen MD; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Zanchin C; Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Stortecky S; Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Spirk D; Department of Pharmacology, Bern University Hospital, Bern, Switzerland, and Sanofi, Switzerland.
  • Siontis GCM; Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Saleh L; Institute of Clinical Chemistry, Zurich University Hospital, Zurich, Switzerland.
  • Matter CM; Department of Cardiology, Zurich University Hospital, Zurich, Switzerland.
  • Daemen J; Department of Cardiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Mach F; Division of Cardiology, University Hospital Geneva, Geneva, Switzerland.
  • Heg D; CTU Bern, University of Bern, Bern, Switzerland.
  • Windecker S; Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Engstrøm T; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Lang IM; Department of Cardiology, Medical University of Vienna, Vienna, Austria.
  • Koskinas KC; Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
JAMA ; 327(18): 1771-1781, 2022 05 10.
Article en En | MEDLINE | ID: mdl-35368058
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Placa Aterosclerótica / Inhibidores de PCSK9 / Infarto del Miocardio Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Año: 2022 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Placa Aterosclerótica / Inhibidores de PCSK9 / Infarto del Miocardio Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Año: 2022 Tipo del documento: Article País de afiliación: Suiza